Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)	autoimmune pulmonary alveolar proteinosis	Active, not recruiting	Phase 3	2026-08-26		NCT04544293

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Savara Inc.	2

54 results · Page 1 of 3

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Aichi Medical University Hospital	Nagakute	Japan	8
Asan Medical Center	Seoul	South Korea	338
Asklepios Fachkliniken Muenchen-Gauting	Muenchen-Gauting	Germany	1
Attikon University Hospital	Athens	Greece	5
Chiba University Hospital - Respiratory Medicine	Chiba	Japan	1
CHU Pontchaillou	Rennes	France	1
Cincinnati Children's Hospital Medical Center	Cincinnati	United States	21
Cleveland Clinic	Cleveland	United States	558
Duke University Medical Center	Durham	United States	505
Ege University Hospital - Department of Pulmonology	Bornova	Turkey (Türkiye)	1
Emory University	Atlanta	United States	262
Fondazione IRCCS Policlinico San Matteo	Pavia	Italy	24
Health Sciences University Gulhane Training and Research Hospital	Ankara	Turkey (Türkiye)	1
Hokkaido University Hospital	Sapporo	Japan	5
Hospital Pulido Valente	Lisbon	Portugal	1
Hospital São João	Porto	Portugal	1
Hospital Universitario de Bellvitge	Barcelona	Spain	1
Hôpital Erasme	Brussels	Belgium	5
Hôpital Louis Pradel	Bron	France	3
Institutul de Pneumoftiziologie "Marius Nasta"	Bucharest	Romania	1
Instytut Gruzlicy i Chorob Pluc	Warsaw	Poland	2
Kanagawa Cardiovascular and Respiratory Center	Yokohama	Japan	5
Kumamoto University Hospital	Kumamoto	Japan	15
Kyorin University Hospital	Mitaka	Japan	13
Loyola University	Maywood	United States	4

Clinical trials